Skip directly to content

tagline 2008 Spring

tagline 2008

  • Toward a Credible National AIDS Strategy in the U.S.
    In April 2008 the Ford Foundation hosted a meeting of over 40 national AIDS leaders to discuss the elements of a national AIDS strategy for the United States. Amazingly, despite the fact that the United States insists that the foreign countries who receive U.S. international AIDS assistance develop and implement a national AIDS strategy, American leaders have never insisted that they develop one for the nation itself. Below are the suggestions TAG’s Mark Harrington—with input from Richard Jefferys, Sue Perez, and Tracy Swan— provided prior to the Ford Foundation meeting.
  • CROI 2008: Webcast Review
    The annual Conference on Retroviruses and Opportunistic Infections—known as CROI—is the most important AIDS research meeting of the year. Thousands of the best scientists and doctors from around the world—and the world recognized by CROI increasingly includes Africa and Asia—meet for three days to look at the latest data and discoveries about HIV and the diseases that accompany it.
  • World CAB 4: The Future of Indian Generic Antiretrovirals
    In April, 25 treatment activists from 16 countries met in New Delhi, India, with representatives of three Indian manufacturers of generic antiretroviral (ARV) drugs. The Indian generic drug industry is a major supplier of affordable ARVs to HIV treatment programs in Africa, and its impact has facilitated placing nearly two million people on lifesaving treatment.
  • What’s in the HIV Drug Pipeline? Not Nearly Enough
    In the midst of a “golden age” of abundant antiretroviral treatments some worry that our “embarrasment of riches” will leave us wanting unless we continue the search for better drugs.
  • HIV Vaccine Research Summit: Hindsight versus Foresight
    While still analyzing data from the third ever AIDS vaccine efficacy trial, the field is serenaded by a chorus of opinions.
  • Complacency Will Inhibit Search for Better HIV Drugs
    Better drugs are urgently needed for most of the people in the world who still lack treatment for HIV. Yet physician contentment with current treatment options in Europe and the United States may hold back research to develop new drugs.